Abstract:Anticancer drug conjugates with metal nanoparticles are in the center of research interest due to the promising application potential in modern medicine. It was proved that plasmonic metal nanoparticles are not only drug carriers and amplifiers of biological effect but also sensors for tracking the fate of the drug in organisms and cells. The formation of drug conjugates with gold (AuNPs) and silver nanoparticles (AgNPs) are widely described in the literature whereas less attention was paid on the formation of anticancer drug conjugates with platinum nanoparticles (PtNPs). These studies were conducted to verify the main hypothesis that conjugates of erlotinib (ERL), belonging to drugs used in non-small cell lung cancer (NSCLCs) treatment, with PtNPs can be formed in electrostatically-driven self-organization process. PtNPs were prepared using a seed-mediated growth method. The micrographs obtained from transmission (TEM) and scanning (SEM) electron microscopy revealed that PtNPs exhibited quasi-spherical shape and an average size equal to 108 ± 11 nm. The stability of PtNPs under controlled pH and ionic strength was determined by dynamic (DLS) and electrophoretic (ELS) light scattering. The formation of ERL-PtNP conjugates was carried out under mild acidic conditions, at pH 4.9 and ionic strength 7 × 10−3 M. The spectroscopic analysis of formed conjugates was performed with the use of surface-enhanced Raman spectroscopy (SERS) and surface-enhanced infrared adsorption spectroscopy (SEIRA). The spectroscopic investigation was carried out for positively charged conjugates. The performed SERS and SEIRA studies indicate that the prepared PtNPs provide effective surface enhancement in visible and infrared regions, respectively, ensuring the possibility to perform detailed characterization of the adsorption process on these metal nanostructures. The considered ERL indicates strong interaction with the PtNPs mainly through the quinazoline and the amino moieties. Also, the ethylene bridge takes part in the conjugates formation, while methoxy moiety and phenylacetylene ring remain at a certain distance from the metal surface. The comparison of obtained results with available literature data showed that the adsorption pattern of ERL strongly depends on the type of plasmonic nanoparticles because the phenylacetylene ring of ERL plays a crucial role in the formation of conjugates with AuNPs and AgNPs. Based on these findings, the chemical structure of ERL in the formed conjugates was proposed. It was concluded that the stable ERL-PtNP conjugates can exhibit comparable electrokinetic properties with ERL conjugates with AuNPs and AgNPs while the chemical structure of ERL layer on nanoparticle surface strongly depends on the plasmonic metal type.

Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy

Design, Synthesis, Anti-Tumor Activity, and Molecular Modeling of Quinazoline and Pyrido[2,3-D]Pyrimidine Derivatives Targeting Epidermal Growth Factor Receptor

Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting

Self-assembled peptide nanoparticles for photodynamic therapy: morphological and mechanical effects on hepatocellular carcinoma cells

Fabrication of programmed photosensitizer-conjugated nanoassemblies by dual supramolecular self-assembly for photodynamic therapy of orthotopic hepatoma

Electrostatic Self-Assembled Iridium(III) Nano-Photosensitizer for Selectively Disintegrated and Mitochondria Targeted Photodynamic Therapy

Amphiphilic porphyrin-based supramolecular self-assembly for photochemotherapy: From molecular design to application

Self-assembly of nanomicelles with rationally designed multifunctional building blocks for synergistic chemo-photodynamic therapy

A physicochemical and spectroscopic characterization of novel erlotinib conjugates with platinum nanoparticles

Supramolecular assemblies with aggregation-induced emission for in situ active imaging-guided photodynamic therapy of cancer cells

Supramolecular Polymerization‐Induced Nanoassemblies for Self‐Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor

Tumor selective self-assembled nanomicelles of carbohydrate-epothilone B conjugate for targeted chemotherapy

Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-b]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors

Photosensitizer-stabilized Self-Assembling Nanoparticles Potentiate Chemo/photodynamic Efficacy of Patient-Derived Melanoma.

Self-Assembled Porphyrin-Peptide Cages for Photodynamic Therapy

Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing a 4,5,6,7-tetrahydrothieno [3,2-c]pyridine as potent EGFR inhibitors

Abstract P6-10-02: Self-assembled nano drugs of pyrotinib and indocyanine green based on photothermal photodynamic therapy

Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation

Nanoparticles Based on Glycyrrhetinic Acid Modified Porphyrin for Photodynamic Therapy of Cancer.

Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy

Biointerface engineering of self-protective bionic nanomissiles for targeted synergistic chemotherapy